Product Related Announcements
Positive results for Facor 8 FC Fusion protein in Hemophilia A
10/31/2012
Special Call, Swedish Orphan Biovitrum AB- Special Call
10/31/2012
Reports Top Line Results of EMPOWER
01/04/2013
Sent FDA application for first long lasting factor 9 therapy for Hemophlia B
01/04/2013
Positive results phase 3 study of Peginterferon Beta -1a in Multiple Sclerosis
01/24/2013
Committee for CHMP issues positive opinion for Biogen’s TECFIDERA
03/22/2013
FDA approval of TECFIDERA as a First Line oral Treatment for Multiple sclerosis
03/27/2013
Canada approves TECFIDERA as a First-Line Oral Treatment for Multiple Sclerosis
04/09/2013